Extracellular vesicles in neurodegenerative diseases

T Croese, R Furlan

Research output: Contribution to journalArticlepeer-review


Extracellular vesicles (EVs) are released by all neural cells, including neurons, oligodendrocytes, astrocytes, and microglia. The lack of adequate technology has not halted neuroscientists from investigating EVs as a mean to decipher neurodegenerative disorders, still in search of comprehensible pathogenic mechanisms and efficient treatment. EVs are thought to be one of ways neurodegenerative pathologies spread in the brain, but also one of the ways the brain tries to displace toxic proteins, making their meaning in pathogenesis uncertain. EVs, however do reach biological fluids where they can be analyzed, and might therefore constitute clinically decisive biomarkers for neurodegenerative diseases in the future. Finally, if they constitute a physiological inter-cell communication system, they may represent also a very specific drug delivery tool for a difficult target such as the brain. We try to resume here available information on the role of EVs in neurodegeneration, with a special focus on Alzheimer's disease, progressive multiple sclerosis, amyotrophic lateral sclerosis, and Huntington's disease. © 2017 Elsevier Ltd.
Original languageEnglish
Pages (from-to)52-61
Number of pages10
JournalMolecular Aspects of Medicine
Issue number1
Publication statusPublished - 2018


Dive into the research topics of 'Extracellular vesicles in neurodegenerative diseases'. Together they form a unique fingerprint.

Cite this